Apyx Medical Inc Total Assets

Latest as of June 2026: $61.07 Million USD

Apyx Medical Inc total assets. Based on the latest financial reports, Apyx Medical Inc (APYX) holds total assets worth $61.07 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see APYX market cap overview for the company's overall valuation and market capitalisation.

Total Assets of Apyx Medical Inc (1995–2025)

Total assets of Apyx Medical Inc from 1995 to 2025. This chart illustrates how Apyx Medical Inc's total assets have evolved over time, based on quarterly financial data. See APYX stock price and chart for real-time trading data and today's change.

Apyx Medical Inc - Asset Composition Analysis

Apyx Medical Inc Total Assets Breakdown (December 2025)

Apyx Medical Inc total assets breakdown as of December 2025. Apyx Medical Inc's total assets of $61.07 Million consist of 87.5% current assets and 12.5% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 47.5%
Accounts Receivable $16.78 Million 25.1%
Inventory $8.60 Million 12.9%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (1995–2025)

This chart illustrates how Apyx Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Apyx Medical Inc's working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Apyx Medical Inc's current assets represent 87.5% of total assets in 2025, an increase from 46.7% in 1995.
  • Cash Position: Cash and equivalents constituted 47.5% of total assets in 2025, up from 4.6% in 1995.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 14.0% in 1995.
  • Asset Diversification: The largest asset category is accounts receivable at 25.1% of total assets.

Apyx Medical Inc Competitors by Total Assets

Key competitors of Apyx Medical Inc based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
Double Medical Technology Inc
SHE:002901
China CN¥5.03 Billion
BMC Medical Co. Ltd. A
SHE:301367
China CN¥3.59 Billion
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $96.98 Million
Emvision Medical Devices Ltd
AU:EMV
Australia AU$24.94 Million
Sequana Medical NV
BR:SEQUA
Belgium €14.57 Million
Hironic Co. Ltd
KQ:149980
Korea ₩80.01 Billion
DRGEM Corporation
KQ:263690
Korea ₩131.65 Billion

Apyx Medical Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.68 4.72 5.11
Quick Ratio 4.53 3.95 4.60
Cash Ratio 0.00 0.00 0.00
Working Capital $43.80 Million $39.35 Million $48.16 Million

Apyx Medical Inc - Advanced Valuation Insights

This section examines the relationship between Apyx Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 11.42
Latest Market Cap to Assets Ratio 1.64
Asset Growth Rate (YoY) 3.1%
Total Assets $66.84 Million
Market Capitalization $109.52 Million USD

Valuation Analysis

Above Book Valuation: The market values Apyx Medical Inc's assets above their book value (1.64x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Apyx Medical Inc's assets grew by 3.1% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Apyx Medical Inc (1995–2025)

The table below shows the annual total assets of Apyx Medical Inc from 1995 to 2025.

Year Total Assets Change
2025-12-31 $66.84 Million +3.08%
2024-12-31 $64.84 Million -18.17%
2023-12-31 $79.24 Million +53.05%
2022-12-31 $51.77 Million -24.66%
2021-12-31 $68.72 Million -7.27%
2020-12-31 $74.11 Million -12.48%
2019-12-31 $84.68 Million -11.44%
2018-12-31 $95.61 Million +208.54%
2017-12-31 $30.99 Million -11.74%
2016-12-31 $35.11 Million +11.64%
2015-12-31 $31.45 Million +26.64%
2014-12-31 $24.83 Million -25.15%
2013-12-31 $33.18 Million +17.72%
2012-12-31 $28.18 Million -0.20%
2011-12-31 $28.24 Million +1.63%
2010-12-31 $27.79 Million +0.73%
2009-12-31 $27.58 Million +7.00%
2008-12-31 $25.78 Million +36.97%
2007-12-31 $18.82 Million +12.80%
2006-12-31 $16.69 Million +41.75%
2005-12-31 $11.77 Million +6.82%
2004-12-31 $11.02 Million +19.33%
2003-12-31 $9.23 Million +8.62%
2002-12-31 $8.50 Million -0.91%
2001-12-31 $8.58 Million +8.40%
2000-12-31 $7.91 Million +7.76%
1999-12-31 $7.34 Million -31.11%
1998-12-31 $10.66 Million +177.77%
1997-12-31 $3.84 Million -1.57%
1996-12-31 $3.90 Million +8.28%
1995-12-31 $3.60 Million --

About Apyx Medical Inc

NASDAQ:APYX USA Medical Devices
Market Cap
$109.52 Million
Market Cap Rank
#18637 Global
#4342 in USA
Share Price
$2.60
Change (1 day)
+0.00%
52-Week Range
$2.36 - $4.86
All Time High
$17.40
About

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and … Read more